Scarica l'app Stockscreener
3.66
8.50%
-0.34
Dopo l'orario di chiusura:
3.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.00
Aprire:
$3.9
Volume 24 ore:
21,477
Relative Volume:
2.18
Capitalizzazione di mercato:
$25.61M
Reddito:
$598.00K
Utile/perdita netta:
$-21.81M
Rapporto P/E:
-0.8883
EPS:
-4.12
Flusso di cassa netto:
$-16.66M
1 W Prestazione:
-16.63%
1M Prestazione:
-17.57%
6M Prestazione:
-29.48%
1 anno Prestazione:
-26.80%
Intervallo 1D:
$3.33
$3.95
Intervallo di 1 settimana:
$3.33
$4.38
Portata 52W:
$3.33
$6.60
Pluri Inc Stock (PLUR) Company Profile
Nome
Pluri Inc
Settore
Industria
Telefono
972-74-710-7171
Indirizzo
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Confronta PLUR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
3.66 | 25.61M | 598.00K | -21.81M | -16.66M | -4.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Pluri Inc Borsa (PLUR) Ultime notizie
Pluristem stock touches 52-week low at $4 amid market challenges By Investing.com - Investing.com South Africa
Pluristem stock touches 52-week low at $4 amid market challenges - Investing.com Australia
BRAINSTORM CELL THERAPEUTICS INC. SEC 10-K Report - TradingView
Pluri Inc. (NASDAQ:PLUR) Sees Large Decrease in Short Interest - Defense World
Pluri Inc. sets date for 2025 annual shareholder meeting By Investing.com - Investing.com Canada
Pluri Inc. sets date for 2025 annual shareholder meeting - Investing.com India
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom - openPR
Plurilock Security (CVE:PLUR) Shares Down 5% – Here’s What Happened - Defense World
Using cell science to fight nuclear weapons: How is Pluri revolutionizing health and food tech? - The Jerusalem Post
Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Ke... - WhaTech
Pluri Inc. partners with Hemafund for radiation emergency response By Investing.com - Investing.com Canada
Pluri Inc. and Hemafund partner for radiation emergency pre By Investing.com - Investing.com Canada
Pluri signs deal to help Ukraine's radiation emergency preparedness - The Pharma Letter
Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise - Marketscreener.com
Pluri Inc. and Hemafund partner for radiation emergency pre - Investing.com India
Pluri Inc. partners with Hemafund for radiation emergency response - Investing.com
Pluri announces exclusive collaboration agreement with Hemafund - TipRanks
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness - The Manila Times
Head-To-Head Survey: Pluri (NASDAQ:PLUR) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
EAF and Buhler announce collaboration - TipRanks
Can This New Technology Finally Make Lab-Grown Meat Affordable? Ever After Foods Says Yes - StockTitan
Pluri Announces Strategic Merger to Enhance Market Position - TipRanks
Pluri Proposes Extension of Convertible Bond Maturity to Key Investor - TipRanks
Pluri: Fiscal Q2 Earnings Snapshot - CT Insider
Pluri: Fiscal Q2 Earnings Snapshot -February 11, 2025 at 05:38 pm EST - Marketscreener.com
Pluri Inc. Faces Financial Challenges Amid Continued Innovation - TipRanks
Pluri Inc. SEC 10-Q Report - TradingView
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology - Business Wire
Pluri Ltd. Strengthens Financial Position Through Capital Raising - TipRanks
Romanian Fintech Company Pluridio is Expanding its Global Presence by Opening a Subsidiary in the UK - PR Newswire
Plurilock Security (CVE:PLUR) Trading Up 4% – Should You Buy? - Defense World
Pluri (NASDAQ:PLUR) Trading Down 4.4% – Time to Sell? - Defense World
Pluri secures additional $3.5 million investment - MSN
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million - The Manila Times
Major Shareholder Doubles Down: Pluri Lands $3.5M Premium Investment as Growth Plans Accelerate - Stock Titan
The Month In Cultivated Meat: January - substack.com
Pluri Inc. Announces Appointment of Alejandro Weinstein to Board of Directors -January 23, 2025 at 07:15 am EST - Marketscreener.com
Liberation labs raises $50.5m: The Week in AgriFoodTech - AgFunderNews
Pluri Strengthens Leadership Amid Strategic Board Appointment - TipRanks
Adipose-Derived Stem Cell Market to Reach $3013.9 Million by 2030. - openPR
Pluri Inc. granted extension to regain Nasdaq compliance - MSN
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market - Yahoo Finance
BeZero closes $32m round: The Week in AgriFoodTech - AgFunderNews
Pluri Inc Azioni (PLUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):